GDG for WHO recommendations on preferred regimens for treating HIV infection
21 May 2019 – WHO has made available the membership of the Guidelines Development Group (GDG) for the 2019 update of the WHO "Recommendations on preferred first-line and second-line antiretroviral regimens for treating HIV infection".
The meeting of the GDG will be held on 5–7 June 2019, and will focus on reviewing the latest evidence on HIV antiretroviral drug efficacy, toxicity and safety. The objective of the meeting will be to provide recommendations and guidance on the preferred first-line and second-line antiretroviral regimens for treating HIV infection among children, adolescents and adults.
In line with WHO policy on conflict of interest, members of the public and interested organizations can access the biographies of the GDG members and inform WHO of their views about them. All comments should be sent by email to firstname.lastname@example.org by 3 June 2019.